eFFECTOR Therapeutics (EFTR) Stock Chart & Stock Price History $0.03 -0.01 (-28.33%) (As of 10/4/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends eFFECTOR Therapeutics Stock Price Performance5 Day Performance-36.75%1 Month Performance-36.75%3 Month Performance-69.70%6 Month Performance-98.99%Year-To-Date Performance-99.78%1 Year Performance-99.83% Receive EFTR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsNotice: Major payout due November 19th - are you on the list?On Tuesday, November 19, 2024 smart investors will collect their share of a $1.2 billion windfall... It's part of a unique strategy which has nothing to do with risky investments like options, cryptos or forex. And while it might sound crazy...Click here for the ticker >>> EFTR Stock Chart for Sunday, October, 6, 2024 EFTR Chart by TradingView eFFECTOR Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/04/2024$0.04$0.03-27.71%$0.04$0.0311,037 shs$119,000.0010/03/2024$0.03$0.04+16.28%$0.04$0.0310,661 shs$165,000.0010/02/2024$0.04$0.03-24.75%$0.04$0.0319,064 shs$142,000.0010/01/2024$0.04$0.04+8.11%$0.04$0.0415,190 shs$188,000.0009/30/2024$0.04$0.04-5.13%$0.04$0.0458,464 shs$174,000.0009/27/2024$0.04$0.04+5.41%$0.04$0.0412,372 shs$183,000.00 Get the Latest News and Ratings for EFTR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/26/2024$0.05$0.04-17.78%$0.05$0.04172,889 shs$174,000.0009/25/2024$0.04$0.05+12.50%$0.05$0.048,618 shs$212,000.0009/24/2024$0.04$0.04-2.44%$0.05$0.0479,872 shs$188,000.0009/23/2024$0.04$0.04-5.20%$0.04$0.041,642 shs$193,000.0009/20/2024$0.04$0.04+1.88%$0.05$0.047,743 shs$204,000.0009/19/2024$0.04$0.04+6.25%$0.05$0.0424,554 shs$200,000.0009/18/2024$0.05$0.04-14.89%$0.05$0.04159,088 shs$188,000.0009/17/2024$0.04$0.05+17.50%$0.05$0.0412,312 shs$221,000.0009/16/2024$0.05$0.04-15.79%$0.05$0.043,983 shs$188,000.0009/13/2024$0.04$0.05+18.75%$0.06$0.0417,355 shs$223,000.0009/12/2024$0.04$0.04$0.06$0.0482,925 shs$188,000.0009/11/2024$0.04$0.04$0.05$0.0416,651 shs$188,000.0009/10/2024$0.04$0.04$0.04$0.042,115 shs$188,000.0009/09/2024$0.04$0.04$0.05$0.042,643 shs$188,000.0009/06/2024$0.04$0.04$0.05$0.0415,261 shs$188,000.0009/05/2024$0.04$0.04+14.29%$0.05$0.03190,340 shs$188,000.0009/04/2024$0.04$0.04-12.50%$0.04$0.0341,322 shs$165,000.0009/03/2024$0.04$0.04$0.04$0.04301 shs$188,000.0009/02/2024$0.04$0.04$0.05$0.037,600 shs$188,000.0008/30/2024$0.03$0.04+29.03%$0.05$0.037,693 shs$188,000.0008/29/2024$0.05$0.03-31.11%$0.05$0.03333,683 shs$146,000.0008/28/2024$0.05$0.05-7.79%$0.05$0.053,020 shs$212,000.0008/27/2024$0.05$0.05+2.52%$0.05$0.054,690 shs$230,000.0008/26/2024$0.05$0.05-2.36%$0.05$0.0512,106 shs$224,000.0008/23/2024$0.05$0.05+8.44%$0.05$0.051,553 shs$230,000.0008/22/2024$0.05$0.05-5.51%$0.05$0.0510,653 shs$212,000.0008/21/2024$0.05$0.05-4.75%$0.05$0.05155,614 shs$224,000.0008/20/2024$0.05$0.05$0.05$0.0562,555 shs$235,000.0008/19/2024$0.05$0.05+0.10%$0.05$0.0574,949 shs$235,000.0008/16/2024$0.05$0.05+2.88%$0.05$0.058,185 shs$235,000.0008/15/2024$0.05$0.05+3.40%$0.06$0.0510,461 shs$229,000.0008/14/2024$0.05$0.05-11.82%$0.06$0.0539,844 shs$221,000.0008/13/2024$0.05$0.05+1.52%$0.05$0.0511,672 shs$251,000.0008/12/2024$0.05$0.05+10.53%$0.06$0.0566,215 shs$247,000.00Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (Ad)Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER…08/09/2024$0.05$0.05+5.56%$0.05$0.055,343 shs$223,000.0008/08/2024$0.05$0.05-10.00%$0.05$0.059,050 shs$212,000.0008/07/2024$0.04$0.05+23.46%$0.05$0.0442,038 shs$235,000.0008/06/2024$0.05$0.04-10.93%$0.05$0.0444,349 shs$191,000.0008/05/2024$0.04$0.05+8.26%$0.05$0.03103,193 shs$214,000.0008/02/2024$0.04$0.04+1.20%$0.04$0.0464,297 shs$197,000.0008/01/2024$0.04$0.04+2.98%$0.05$0.0414,501 shs$195,000.0007/31/2024$0.04$0.04-5.18%$0.04$0.0417,603 shs$200,000.0007/30/2024$0.05$0.04-8.60%$0.06$0.0453,721 shs$200,000.0007/29/2024$0.05$0.05+1.09%$0.06$0.0558,205 shs$219,000.0007/26/2024$0.05$0.05-1.08%$0.05$0.0524,738 shs$216,000.0007/25/2024$0.05$0.05-2.31%$0.06$0.0531,009 shs$219,000.0007/24/2024$0.06$0.05-13.45%$0.06$0.0587,102 shs$224,000.0007/23/2024$0.06$0.06-6.14%$0.06$0.0553,571 shs$258,000.0007/22/2024$0.06$0.06+6.55%$0.06$0.0524,485 shs$275,000.0007/19/2024$0.05$0.06+1.66%$0.06$0.0517,291 shs$258,000.0007/18/2024$0.06$0.05-1.64%$0.07$0.0510,874 shs$254,000.0007/17/2024$0.05$0.06+8.91%$0.06$0.05147,345 shs$259,000.0007/16/2024$0.06$0.05-16.11%$0.09$0.05293,865 shs$237,000.0007/15/2024$0.08$0.06-25.22%$0.09$0.0672,885 shs$283,000.0007/12/2024$0.04$0.08+123.61%$0.10$0.07180,425 shs$379,000.0007/11/2024$0.04$0.04$0.08$0.03353,773 shs$169,000.0007/10/2024$0.05$0.04-22.41%$0.06$0.03353,773 shs$169,000.0007/09/2024$0.05$0.05-0.85%$0.06$0.05239,510 shs$218,000.0007/08/2024$0.08$0.05-43.95%$0.10$0.05448,519 shs$220,000.0007/05/2024$0.13$0.08-35.77%$0.16$0.08490,509 shs$392,000.00 Related Companies: Aptevo Therapeutics Stock Price Chart Comera Life Sciences Stock Price Chart PolarityTE Stock Price Chart TRACON Pharmaceuticals Stock Price Chart Bellerophon Therapeutics Stock Price Chart Biodexa Pharmaceuticals Stock Price Chart Smart for Life Stock Price Chart PainReform Stock Price Chart NexImmune Stock Price Chart China SXT Pharmaceuticals Stock Price Chart Receive EFTR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EFTR) was last updated on 10/6/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHow a $200,000 Mistake Unlocked a $118 Billion Gold TreasureThe window of opportunity on this gold stock is closing fast. Once word gets out, it may be too late.Monument Traders Alliance | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredHow much money are you leaving on the table from the stocks you already own?Charles Payne here, and I want to let you in on a time-tested trading method that can be used to generate cash...Unstoppable Prosperity | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredGolden Equation: Volatility = OpportunityWhen the market swings wildly, most investors panic… But it doesn't have to be this way. You see, when t...Prosper Trading Academy | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding eFFECTOR Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share eFFECTOR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
